26 1 □종설 □
임상적용을 위한 세포치료제로서의 성체 중간엽줄기세포
*Abstract
- -
서 론
줄기세포의 종류
중간엽줄기세포의 배양 및 특징
A B
α
세포치료제로서의 활용성
β
A B
β
A B
A B
결 론
참 고 문 헌
전체 글
26 1 □종설 □
Abstract
- -
서 론
줄기세포의 종류
중간엽줄기세포의 배양 및 특징
A B
α
세포치료제로서의 활용성
β
A B
β
A B
A B
결 론
참 고 문 헌
관련 문서
Here, we found that TAMR-MCF-7 cells had undergone EMT, evidenced by mesenchymal-like cell shape, down-regulation of the basal E-cadherin expression
In vitro cell migration in APE or JAG1 siRNA-treated M059K cell line Fig,11 Down-regulation of JAG1 induces S phase arrest in
LIPUS therapy is a recently developed method for application of mechanical stress, and used clinically to promote bone healing. Author evaluated the effect
In contrast, cells expressing wild-type form or constitutively active form of RapC (GFP-RapC and GFP-RapC G13V ) showed decreased cell area and cell adhesion, whereas rapC
Approved clinical use of bone marrow stem cells for myocardial infarction treatment... Cardiac
Department of Education, National Center for Educational Statistics, Adult Literacy in America, National Adult Literacy Survey, 1992, Table 1.1b, p.. In addition, the United
In this work, processing techniques for producing microcellular silicon carbide with cell densities greater than 10 9 cells/㎤ and cells smaller than 30㎛ have
Meterials and Methods: Our study involved three stem cell sources-subacromial bursal tissue, bone marrow, and umbilical cord-derived stem cells. Under consent we